Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-760-9 | CAS number: 150-46-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
An initial limit dose of 2,000 mg/kg of body weight was administered to one healthy female rat by oral gavage. Due to the absence of mortality in this animal, four additional females were sequentially dosed at the same dose level. Since all animals survived, no additional animals were tested.
Following administration, clinical signs noted for all animals included piloerection, facial staining, hypoactivity, andlor reduced fecal volume. However, all animals recovered by Day 2, and appeared active and healthy for the remainder of the 14-day observation period. No mortality was noted during the study period.
Under the conditions of this study, the acute oral LD50 of Trirmethyl Borate is greater than 2000 mg/kg of body weight in female rats and Trimethyl Borate will not be classified in respect of its acute oral toxicity.
Based on the supplied read-across justificatuion, this result is also relevant for Triethyl Borate.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Referencing ECHA's Read-Across Assessment Framework (RAAF) as basis, an analogue approach is used to assess the read-across potential for the target substance triethyl borate (CAS 150-46-9 , EC 205-760-9) from the source substance trimethyl borate (CAS 121-43-7, EC 204-468-9).
This read-across is based on the hypothesis that source and target substances are structurally similar substances, which have similar toxicological properties because they rapidly hydrolyse to a common product: Boric acid, and to non-common compounds which does not influence the prediction of the property under consideration (based on worst-case approach) worst-case approach).
Boric acid is very well absorbed following oral administration. In the body, boric acid diffuses into body fluids (highly soluble in water, with an extremely low log Kow). Boric acid is not metabolized and over 90% of the boric acid dose administered is excreted in the urine, irrespective of the administration rout. - Reason / purpose for cross-reference:
- read-across source
- Preliminary study:
- not applicable
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was noted during the study period.
- Clinical signs:
- Following administration, clinical signs noted for all animals included piloerection, facial staining, hypoactivity, andlor reduced fecal volume. However, all animals recovered by Day 2, and appeared active and healthy for the remainder of the 14-day observation period.
- Body weight:
- All animals gained weight during the study period.
- Gross pathology:
No gross abnormalities were noted for any of the animals when necropsied at the conclusion of the 14-day observation period.- Other findings:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study, the acute oral LD50 of Trimethyl Borate is greater than 2000 mg/kg of body weight in female rats and as per Guidance to Regulation (EC) No. 1272/2008 on Classification, Labelling and Packaging of substances and mixtures, Trimethyl Borate will not be classified. Based on read-across result is also relevant for Triethyl borate
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-05-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to OECD TG 425, OPPTS 870.1100 and in accordance with the Principles of Good Laboratory Practice (GLP)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
- Limit test:
- yes
- Specific details on test material used for the study:
- Name of test material (as cited in study report): Trimethyl borate- Physical state: clear liquid with an alcohol odor- Composition of test material, percentage of components: > 99%- Lot/batch No.: Lot #42Y4A09T, TD#04-001 further identified with PSL Reference Number 040210-3R- Stability under test conditions: Test substance was expected to be stable for the duration of testing.- Storage condition of test material: stored in a tightly closed container, at room temperature
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: Received from Ace Animals, Inc., Boyertown, PA- Age at study initiation: 11-12 weeks- Weight at study initiation: 221-247 grams at experimental start- Fasting period before study: yes- Housing: The animals were singly housed in suspended stainless steel caging with mesh floors which conformed to the size recommendations in the Guide for the Care and Use ofLaboratoiy Animals DHEW (NIH). Litter paper was placed beneath the cage and was changed at least three times per week.- Diet (e.g. ad libitum): Purina Rodent Chow #5012 was supplied ad-libitum (except during pre-dose fasting)- Water (e.g. ad libitum): Filtered tap water was supplied ad-libitum by an automatic water dispensing system.- Acclimation period: 20-28 daysENVIRONMENTAL CONDITIONS- Temperature (°C): 18-22 °C- Humidity (%): 33-68%- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Individual doses were calculated based on the initial body weights, taking into account the specific gravity (determined by PSL) of the test substance - Specific Gravity - 0.930 g/ml
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- An initial limit dose of 2,000 mg/kg of body weight was administered to one healthy female rat by oral gavage. Due to the absence of mortality in this animal, four additional females were sequentially dosed at the same dose level. Since all animals survived, no additional animals were tested.
- Control animals:
- no
- Details on study design:
- Duration of observation period following administration: 14 days - The animals were observed for mortality, signs of gross toxicity, and behavioral changes during the first several hours post-dosing and at least once daily thereafter for 14 days after dosing. Observations included gross evaluation of skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and behavior pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhea and coma.- Frequency of observations and weighing: Individual body weights of the animals were recorded prior to test substance administration (initial) and again on Days 7 and 14 or (termination) after dosing- Necropsy of survivors performed: yes
- Statistics:
- not applicable
- Preliminary study:
- not applicable
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was noted during the study period.
- Clinical signs:
- Following administration, clinical signs noted for all animals included piloerection, facial staining, hypoactivity, andlor reduced fecal volume. However, all animals recovered by Day 2, and appeared active and healthy for the remainder of the 14-day observation period.
- Body weight:
All animals gained weight during the study period.- Gross pathology:
- No gross abnormalities were noted for any of the animals when necropsied at the conclusion of the 14-day observation period.
- Other findings:
- None
- Interpretation of results:
- other: not classified
- Remarks:
- Migrated informationCriteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the acute oral LD50 of Trirnethyl Borate is greater than 2000 mg/kg of body weight in female rats and as per Guidance to Regulation (EC) No. 1272/2008 on Classification, Labelling and Packaging of substances and mixtures, Trimethyl Borate will not be classified
- Executive summary:
An acute oral toxicity test (Up and Down Procedure) was conducted with rats to determine the potential for Trimethyl Borate (Lot# Lot #42Y4A09T, TD#04-001, >99% Trimethyl Borate) to produce toxicity from a single undiluted dose via the oral route. An initial limit dose of 2,000 mg/kg of body weight was administered to one healthy female rat by oral gavage. Due to the absence of mortality in this animal, four additional females were sequentially dosed at the same dose level. Since all animals survived, no additional animals were tested.
All animals survived exposure to the test substance and gained body weight. Following administration, clinical signs noted for all animals included piloerection, facial staining, hypoactivity, and/or reduced fecal volume. However, all animals recovered by Day 2, and appeared active and healthy for the remainder of the 14-day observation period. No gross abnormalities were noted for any of the animals when necropsied at the conclusion of the 14-day observation period.
Under the conditions of this study, the acute oral LD50 of Trirnethyl Borate is greater than 2000 mg/kg of body weight in female rats and as per Guidance to Regulation (EC) No. 1272/2008 on Classification, Labelling and Packaging of substances and mixtures, Trimethyl Borate will not be classified.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1972
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards with acceptable restrictions.
- Qualifier:
- according to guideline
- Guideline:
- other: no data
- Deviations:
- not specified
- Principles of method if other than guideline:
- Boric acid was administered orally by gavage to six groups of five male and five female albino Sprague-Dawley rats. The test material was administered as a 50 % w/v suspension in 0.5 % aqueous methyl cellulose at dosage levels of 2.0; 2.5; 3.16; 3.98; 5.01 and 6.31 g/kg bw. Rats were fasted for a period of 3 to 4 h prior to dosage. Animals were observed for mortality and toxic effects at 1, 2, 4, and 24 h and once daily after for a total of 14 days. At teh end of the observation period the surviving animals were weighed sacrificed and autopsies were performed.
- GLP compliance:
- no
- Remarks:
- Study pre-dates GLP
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material: Boric acid
- Substance type: Solid
- Physical state: Fine soft white powder
- Analytical purity: > 99 % - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: Males: 267 - 302 g; Females: 214 - 248 g - Route of administration:
- oral: gavage
- Vehicle:
- other: 0.5 % aqueous methyl cellulose
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 50 % w/v
MAXIMUM DOSE VOLUME APPLIED: 3450 - 4080 mg/kg bw - Doses:
- 2.0; 2.5; 3.16; 3.98; 5.01 and 6.31 g/kg bw.
- No. of animals per sex per dose:
Five animals/group; no further data- Control animals:
- no
- Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical signs- Statistics:
Litchfield and Wilcoxon- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 450 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 2 950 - 4 040
- Remarks on result:
- other: mg boric acid/kg
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 4 080 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 640 - 4 560
- Remarks on result:
- other: mg boric acid/kg bw
- Mortality:
- No data
- Clinical signs:
- Symptoms include sings of CNS depression, ataxia, convulsions, laboured breathing or rapid respiration; blood crust around nose, marked diarrhoea and ptosis.
- Body weight:
- No data
- Gross pathology:
Autopsies indicated congestion of lungs, kidneys and adrenals; inflammation of the pyloric portion of stomach and small intestine.- Other findings:
- No data
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral LD50 of boric acid for male albino rats was 3450 (2950 - 4040) mg boric acid/kg, equivalent to 604 mg B/kg bw. In female albino rats the acute oral LD50 of boric acid was 4080 (3640 - 4560) mg boric acid/kg, equivalent to 714 mg B/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1970
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Acceptable, study with sufficient basic documentation to demonstrate that study meets basic scientific principles and contains enough detail to be able to judge the results reliable as a contribution to the understanding of the acute toxicity of this substance.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- observations for only 24 hours, no necropsy and histopathology reported as carried out.
- Principles of method if other than guideline:
- The study used both old and young test animals to assess for any differences in sensitivity due to age.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Specific details on test material used for the study:
- No data
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Woodlyn Farms, Guelph, Ontario.
- Age at study initiation: young animal cohort: 100 days old. Old animal cohort: 10 - 12 months.
- Fasting period before study: overnight
- Housing: individually in stock cages.
- Diet: ad libitum, standard lab chow (ex Master Fox Cubes, Toronto Elevators Ltd)
- Water: ad libitum, tap - Route of administration:
- oral: unspecified
- Vehicle:
- water
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: Ethanol was given as a 40% w/v solution in water.
- Doses:
- 6 to 8 dose levels with a dose interval of 1.1 used.
- One dose per time period.
- Exposure duration: Not applicable. - No. of animals per sex per dose:
- 10
- Details on study design:
- - Duration of observation period following administration: 24 hours
- Necropsy findings: not conducted - Statistics:
- LD50 estimated by the moving average method of Weil (Biometrics, 8, 249, 1952) or by the graphical technique of Litchfield and Wilcoxon (J Pharmacol Exp Ther, 96, 99, 1949)
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 10 600 mg/kg bw
- 95% CL:
- > 10 000 - < 11 200
- Remarks on result:
- other: result for young animals
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 7 060 mg/kg bw
- 95% CL:
- > 6 670 - < 7 460
- Remarks on result:
- other: result for old animals
- Mortality:
- All deaths occurred within 24 hours. Individual times not given.
- Clinical signs:
- Description, severity, time of onset and duration of clinical signs at each dose level were not described.
- Other findings:
- - Potential target organs: cause of death was respiratory failure.
- Sex comparison: not applicable. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Old rats were considerably more sensitive than young rats.
- Executive summary:
An acute toxicity study examined the effect of age of male rats on the oral LD50. Using a relatively large number of animals and 6 -8 doses, an LD50 value of 10600mg/kg was obtained for young animals (~100 days old) whereas a significantly lower figure of 7060mg/kg was obtained for older rats (~11 -12 months old). Animals were only observed for a period of 24 hours, although it is unlikely that significant deaths would have occurred after this point due to the known toxicokinetics of metabolism. For those animals that died death wa due to respiratory failure.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Read-Across and assessment entities Boric Acid and Ethanol
Additional information
Justification for classification or non-classification
Referencing ECHA's Read-Across Assessment Framework(RAAF) as basis,
the source substance Trimethyl borate (CAS121 -43 -7, EC204 -468 -9)and the target substance Triethyl borate(CAS150 -46 -9, EC205 -760 -9) are structurally similar substances, which rapidly hydrolize to a common product (Boric acid), and to non-common compounds which does not influence the prediction of the properties under consideration (based on worst-case approach), and therefore they will exhibit similar toxicokinetic behaviour.
Under the conditions of this study, the acute oral LD50 of Trirmethyl Borate is greater than 2000 mg/kg of body weight in female rats and as per Guidance to Regulation (EC) No. 1272/2008 on Classification, Labelling and Packaging of substances and mixtures, Trimethyl Borate will not be classified in respect of its acute oral toxicity, and this is also relevant for Triethyl Borate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.